Switch to:
More From Other Websites
4 Low P/CF Stocks to Improve Your Value Investing Jul 22 2016
IMPAX LABORATORIES INC Files SEC form 8-K, Change in Directors or Principal Officers Jul 21 2016
Impax Names Douglas S. Boothe President of Generics Division Jul 21 2016
Impax Laboratories, Inc. – Value Analysis (NASDAQ:IPXL) : July 19, 2016 Jul 19 2016
Coverage Initiated on Select Healthcare Stocks Jul 14 2016
Why the Teva Acquisition Proves It Is a Stock to Own for the Decade Jul 13 2016
Impax Laboratories, Inc. breached its 50 day moving average in a Bullish Manner : IPXL-US : July 13,... Jul 13 2016
Impax to Report Second Quarter 2016 Results on August 9, 2016 Jul 07 2016
Impax to Report Second Quarter 2016 Results on August 9, 2016 Jul 07 2016
[$$] Teva and Allergan Sell Generic Drugs to Impax In Latest Divestiture Jun 28 2016
Impax Laboratories, Inc. -- Moody's: Impax's Debt-Funded Acquisition of Generics Products is Credit... Jun 22 2016
Impax (IPXL) Stock Declines on Deal to Buy Generic Products Jun 22 2016
Stocks rise after Fed’s Janet Yellen takes a cautious tone on interest rates Jun 21 2016
Impax Buys Mystery Generics Portfolio From Teva, Allergan Jun 21 2016
Impax Buying Teva, Allergan Drugs, Clearing Way For Deal Closing Jun 21 2016
Impax Labs upgraded by BofA/Merrill Jun 21 2016
Impax (IPXL) Stock Tumbles on Teva, Allergan Generic Drug Deal Jun 21 2016
$586M deal: Impax buying generic drugs FTC asked Teva and Allergan to sell Jun 21 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK